We recently reported that Scg3 binds selectively to diseased but not healthy retinas, and that anti-Scg3 hAb selectively inhibits pathological but not physiological angiogenesis with no detectable side effects on healthy vessels in animal models of ROP [18]. The gene discussed is SCG3; the disease is retinopathy of prematurity.